| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 9 |
| 1 | LOTEPREDNOL ETABONATE | 7 |
| 2 | BRIMONIDINE TARTRATE | 5 |
| 3 | FLUOROMETHOLONE | 4 |
| 4 | CETIRIZINE HYDROCHLORIDE | 3 |
| 5 | OLOPATADINE | 3 |
| 6 | TOBRAMYCIN | 3 |
| 7 | TOBRAMYCIN SOLUTION | 3 |
| 8 | TOBRAMYCIN SULFATE | 3 |
| 9 | ADALIMUMAB | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15% | 1 | 0.0096 |
| 1 | BENZETHONIUM CHLORIDE | 1 | 0.0078 |
| 2 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 2 | 0.0018 |
| 3 | LOTEPREDNOL ETABONATE | 7 | 0.0013 |
| 4 | FLUOROMETHOLONE | 4 | 0.0012 |
| 5 | ALCAFTADINE | 1 | 0.0011 |
| 6 | OXYMETAZOLINE HYDROCHLORIDE OPHTHALMIC | 2 | 0.0008 |
| 7 | ARTIFICIAL TEARS | 2 | 0.0008 |
| 8 | POLYVINYL ALCOHOL, POVIDONE | 2 | 0.0008 |
| 9 | BROMFENAC SODIUM | 1 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Volume Expander [EPC] | 2 | 0.0006 |
| 1 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 2 | Interleukin-13 Antagonist [EPC] | 1 | 0.0001 |
| 3 | Recombinant Human Nerve Growth Factor [EPC] | 2 | 0.0001 |
| 4 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 5 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 6 | Aminoglycoside Antibacterial [EPC] | 3 | 0.0001 |
| 7 | Anticholinergic [EPC] | 1 | 0.0001 |
| 8 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |
| 9 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |